Kineta Presents at 22nd Annual Needham Healthcare Conference -…
SEATTLE, April 3, 2023 (GLOBE NEWSWIRE) — Kineta, Inc. KAa clinical-stage biotechnology company focused on developing novel immunotherapies in oncology that address the immune resistance